๋ชฉ์ฐจ

  • ์ˆ˜์•ก ์น˜๋ฃŒ๋Š” resuscitation์˜ ๊ธฐ๋ณธ.
  • ๋‚ด์›ํ•œ ํ™˜์ž์˜ 90-95%๋Š” ์ˆ˜์•ก๋ถ€ํ„ฐ ๊ฝ‚๊ณ  ์‹œ์ž‘. (but 50% ์ด์ƒ์ด ๋ถ€์ ์ ˆํ•œ ์กฐ์น˜)

Common mistakes

Too muchํ•˜๊ฒŒ ์ค„ ๋•Œ๊ฐ€ ๋งŽ๋‹ค!

  • ์ˆ˜์•ก์ด ํ•„์š” ์—†๋Š”๋ฐ ์ฃผ๊ฑฐ๋‚˜, ๋„ˆ๋ฌด ๋งŽ์€ ์ˆ˜์•ก์„ ๋„ฃ๊ฑฐ๋‚˜
  • ๋ถ€์ ์ ˆํ•œ ์œ ํ˜•์„ ์ฃผ๊ฑฐ๋‚˜, ๋ถˆํ•„์š”ํ•˜๊ฒŒ ๊ธธ๊ฒŒ ์ฃผ๊ฑฐ๋‚˜

(ํ˜น์€ ํ•„์š”ํ•œ๋ฐ ์ฃผ์ง€ ์•Š๋Š” ๊ฒฝ์šฐ, ์ถฉ๋ถ„ํ•œ ์ˆ˜์•ก์„ ์ฃผ์ง€ ์•Š๋Š” ๊ฒฝ์šฐ)

1. Fluid therapy = Drug therapy

  • ์šฉ๋Ÿ‰์— ๋”ฐ๋ฅธ ํšจ๊ณผ ์ฐจ์ด๋„ ํฌ๊ณ , ์ฒ˜๋ฐฉ(prescription)์ด ํ•„์š”ํ•จ.
  • ์ˆ˜์•ก์„ ์ฃผ๋Š” ๊ทผ๊ฑฐ(reason)์ด ์žˆ์–ด์•ผ ํ•จ
  • ํ™˜์ž์— ๋”ฐ๋ฅธ ๊ฐœ์ฒด ์ฐจ์ด ๊ณ ๋ คํ•ด์•ผ ํ•จ

์ˆ˜์•ก์„ ์™œ ์ค˜์•ผ ํ• ๊นŒ? (Reason for giving)

  • Fluid deficit์„ ์ฑ„์›Œ์ฃผ๋Š” ๊ฒƒ. (dehydration, hypovolemic)
  • Continuous loss๋ฅผ ๋ฉ”์›Œ์ฃผ๋Š” ๊ฒƒ. (excessive loss, maintenance; ์œ ์ง€์šฉ๋Ÿ‰์„ ๋ฉ”์šฐ์ง€ ๋ชปํ•  ๋•Œ)
  • ์•ฝ๋ฌผ์„ ์ˆ˜์•ก์— ํƒ€์„œ Vehicle๋กœ์„œ ์‚ฌ์šฉ (bolous, CRI) - ๊ณผํ•˜๊ฒŒ ์ˆ˜์•ก ๋“ค์–ด๊ฐˆ ์ˆ˜ ์žˆ์Œ์„ ๊ณ ๋ ค. (other medication/electrolytes)

But ํ˜„์‹ค์ ์œผ๋กœ ์ˆ˜์•ก์„ ์ฃผ๋Š” ํ”ํ•œ ์ด์œ ..?

  • ๋ฌด์—‡์„ ํ•ด์•ผ ํ• ์ง€ ๋ชฐ๋ผ์„œ, ๊ต์ˆ˜๋‹˜์ด ์‹œ์ผœ์„œ, ๋‚ด ๋งˆ์Œ์˜ ์•ˆ์ •..
  • ์—ด์„ ๋‚ด๋ฆฌ๊ธฐ ์œ„ํ•ด : ๋ถ€์ž‘์šฉ์ด ๋” ํด ์ˆ˜ ์žˆ์Œ
  • ๋ณดํ˜ธ์ž์˜ ์š”์ฒญ

โœณ๏ธ Fluid distribution (60:40:20 rule)

  • ์šฐ๋ฆฌ ๋ชธ์˜ 60% = ๋ฌผ
    • ๋ฌผ(60) ์ค‘ 40% = ICF (์„ธํฌ๋‚ด์•ก) : ์„ธํฌ๋Š” ๊ฐ€์žฅ ํฐ ๋ฌผํƒฑํฌ (ํ˜ˆ์•ก ์ชฝ์œผ๋กœ ๊ณ„์† shifting)
    • ๋‚˜๋จธ์ง€ 20% = ECF (์„ธํฌ์™ธ์•ก)
      • ECF์˜ 75%๋Š” interstital fluid, 25%๋Š” plasma

์ˆ˜์•ก์„ ์–ด๋””๋กœ ์ค˜์•ผ ํ• ๊นŒ? (Where is the deficit?)

  • ์ง€์†์ ์ธ ๊ตฌํ†  ์„ค์‚ฌ๋กœ ํƒˆ์ˆ˜๊ฐ€ ์‹ฌํ•˜๋‹ค๋ฉด โ†’ ๊ณ„์† ํ˜ˆ์•ก ์ชฝ์œผ๋กœ shifting์ด ์ผ์–ด๋‚˜ ์„ธํฌ ๋‚ด๋ถ€ fluid ๋ถ€์กฑ โ‡’ ์„ธํฌ ์ฑ„์›Œ์•ผ
  • ๊ตํ†ต์‚ฌ๊ณ ๋กœ ์‹ฌํ•œ ์ถœํ˜ˆ โ†’ ํƒˆ์ˆ˜ ์—†์Œ, ๋น ๋ฅธ ์†๋„๋กœ ํ˜ˆ์•ก์ด ๋น ์ง„ ๊ฒƒ, absolute hypovolemia โ‡’ ํ˜ˆ์•ก ์ฑ„์›Œ์•ผ
ResuscitationRehydrationMaintenance
Hypovolemia ๊ต์ •
: ํ˜ˆ๊ด€๋‚ด (ํ˜ˆ์•ก) target
Dehydration ๊ต์ •
(Extravascular fluid์˜ ์žฌ๋ฐฐ์น˜)
: ์„ธํฌ๋‚ด (๊ฐ„์งˆ) target
์ •์ƒ ์ˆ˜ํ™” ์ƒํƒœ ์œ ์ง€
*์‡ผํฌ ์ฆ์ƒ ํ™•์ธ*ํƒˆ์ˆ˜ ์ •๋„ ํ‰๊ฐ€

2. Types of Fluids (์ˆ˜์•ก ์ข…๋ฅ˜ ๊ฒฐ์ •)

4Ds : ์ˆ˜์•ก ์“ธ ๋•Œ ๊ณ ๋ คํ•  4๊ฐ€์ง€

Drug / Dose / Duration / De-escalation

โœณ๏ธ Fluid์˜ ์ข…๋ฅ˜

์ˆ˜์•ก์˜ ์ข…๋ฅ˜๋Š” ํฌ๊ฒŒ 2๊ฐ€์ง€(+ํ˜ˆ์•ก)๋กœ ๋‚˜๋ˆŒ ์ˆ˜ ์žˆ๋‹ค!

  • crystalloid : ํ˜ˆ๊ด€๋ง‰์„ ์‰ฝ๊ฒŒ ์ด๋™ํ•จ โ‡’ ๊ฐ„์งˆ ๋ณด์ถฉ
  • colloid : ๋ถ„์ž๋Ÿ‰์ด ์ปค์„œ ํ˜ˆ๊ด€์„ ํ†ต๊ณผํ•˜์ง€ ๋ชปํ•จ โ†’ ํ˜ˆ๊ด€ ๋‚ด ์‚ผํˆฌ์••์„ ๋†’์—ฌ ๋ฌผ์„ ๋Œ์–ด์˜ด โ‡’ ํ˜ˆ์•ก๋Ÿ‰ ๋ณด์ถฉ (์ˆ˜์•ก์˜ ์ ˆ๋Œ€๋Ÿ‰ + ๋Œ์–ด์˜จ ๋ฌผ = ์šฉ๋Ÿ‰ ๋ปฅํŠ€๊ธฐ)
  • Blood transfusion : ์ ํ˜ˆ๊ตฌ๋ฅผ ๋„ฃ์–ด์ค˜์„œ ๋นˆํ˜ˆ ๋ฐ ์ถœํ˜ˆ ๊ฐœ์„ 
Crystalloid
water, sodium, glucose base +@
๋ถ„์ž๋Ÿ‰์ด ์ž‘์Œ. ์„ธํฌ๋ง‰์„ ์™”๋‹ค๊ฐ”๋‹ค ์ž์œ ๋กญ๊ฒŒ ์›€์ง์ž„. (fluid shift)
๋น ๋ฅด๊ฒŒ redistribution ๋จ. (30๋ถ„ ์•ˆ์— 75%๊ฐ€ ๊ฐ„์งˆ์ด๋‚˜ ์„ธํฌ๋กœ ์žฌ๋ถ„๋ฐฐ.) โ†’ ํƒˆ์ˆ˜ ๊ต์ •์— ์œ ์šฉ
์žฅ๊ธฐ๋ถ€์ข… ์œ ๋ฐœ ๊ฐ€๋Šฅ (ํŠนํžˆ ํ๋ถ€์ข…)
Hypotonic (0.45%) / Isotonic (0.9%) / Hypertonic (3-7%)
Colloid
ํ˜ˆ๊ด€ ์•ˆ์— ๋จธ๋ฌผ๋ฉฐ Intravascular ์‚ผํˆฌ๋ฅผ ์œ ์ง€ ๋˜๋Š” ๋Š˜๋ฆผ.
Volume expansion ํšจ๊ณผ๊ฐ€ ์•„์ฃผ ํผ. (์ฃผ๋ณ€์—์„œ ๋Œ์–ด์˜ค๋Š” ์–‘๊นŒ์ง€, ํˆฌ์—ฌ๋Ÿ‰๋ณด๋‹ค 2-3๋ฐฐ ์ •๋„)
Intravascular ์•ˆ์—์„œ ํ•˜๋ฃจ๊นŒ์ง€ ๋จธ๋ฌด๋ฆ„ (long-lasting)
๐Ÿ“‰ LFVR (Limited Fluid Volume Resuscitation) : Small volume์œผ๋กœ ์ตœ์ ์˜ resuscitation
(์›๋ž˜๋Š” 80-90ml/kg๋ฅผ maximum์œผ๋กœ ๋ณด๊ณ  1/4์”ฉ 4๋ฒˆ๊นŒ์ง€๋„ ์คŒ. โ†’ Expansion ํšจ๊ณผ๋กœ ์ธํ•ด ํ˜ˆ์•ก ๋ฐ ์‘๊ณ  ์ธ์ž ํฌ์„, ํ˜ˆ๊ด€์ธต ๋ฌด๋„ˆ์ง, ์‚ฐ์ฆ ๋“ฑ ๋ถ€์ž‘์šฉ. โ‡’ ์ด์   Maximum 30ml/kg์„ ๊ถŒ์žฅ๋Ÿ‰์œผ๋กœ ๋ด„.)
First choice๋Š” ์•„๋‹˜. ํ•ฉ๋ณ‘์ฆ์ด ๋ฐœ์ƒํ•˜๋ฉด ์น˜๋ช…์  (AKI, coagulopathy์‘๊ณ ๋ณ‘์ฆ)
Crystalloid๋ฅผ ๋จผ์ € ์“ฐ๋˜, ๊ณ„์† ๋น ์ง€๊ฑฐ๋‚˜ ํ•ฉ๋ณ‘์ฆ(์กฐ์ง๋ถ€์ข…)์ด ์˜์‹ฌ๋  ๋•Œ Colloid๋ฅผ add-on.
์ˆ˜์•ก ์„ ํƒ - Hypovolemia? Dehydration?

Ex. 10% ํƒˆ์ˆ˜ + hypovolemic ํ™˜์ž๊ฐ€ ์žˆ๋‹ค๋ฉด,

  • ๋“ฑ์žฅ์„ฑ crystalloid๋ฅผ ๋จผ์ € ์ซ™ โ†’ ์„ธํฌ ์ˆ˜ํ™” ๋  ๋•Œ์ฏค maintenance ์šฉ์œผ๋กœ ์ €์žฅ์„ฑ crystalloid โ†’ ๊ท ํ˜•์ด ์žกํžˆ๋ฉด colloid
  • ๋งŒ์•ฝ ๊ฐ„์งˆ/์„ธํฌ์— fluid๊ฐ€ ๋‹ค ๋น ์ง„ ์ƒํƒœ์—์„œ colloid๋ฅผ ๋จผ์ € ์“ฐ๋ฉด,
    • (๋ฌผ์„ ๊ณ„์† ๋Œ์–ด์˜ค๋‹ˆ๊นŒ) ํƒˆ์ˆ˜ ์•…ํ™”
    • ํ, ๋‡Œ์—๋„ ์˜ํ–ฅ โ‡’ Colloid๋Š” ํƒˆ์ˆ˜๋ฅผ ๋‹ค ๊ต์ •ํ•œ ์ƒํƒœ์—์„œ!
Hypovolemia w/ dehydration (ex. 12% ํƒˆ์ˆ˜ + BP 60)
Isotonic crystalloid
: ๋‘˜ ๋‹ค targetํ•˜๋˜, ์ผ๋‹จ ๋“ฑ์žฅ์„ฑ crystalloid๋กœ ์ถฉ๋ถ„ํžˆ resuscitation
Hypovolemia w/o dehydration (ex. ์™ธ์ƒ & ์‹ฌํ•œ ์ถœํ˜ˆ)
crystalloid (1-2 aliquots) + Colloid
: ํ˜ˆ๊ด€ ์•ˆ์„ targetํ•˜๋˜ (colloid)
: ๊ฐ„์งˆ์ด๋‚˜ ์„ธํฌ๋„ ์ถฉ๋ถ„ํžˆ ์ˆ˜ํ™”๋  ์ˆ˜ ์žˆ๋„๋ก crystalloid ์กฐ๊ธˆ ์จ์ค˜๋„ ์ข‹์Œ (10ml 1๋ฒˆ ์ •๋„)
Hypovolemia w/ cerebral, pulmonary damage
LFVR๋กœ ์ˆ˜์•ก ์šฉ๋Ÿ‰ ์กฐ์ ˆ
: ํ, ๋‡Œ๋Š” ๋ถ€์ข…์— ๊ฐ€์žฅ ์ทจ์•ฝ, ์กฐ๊ธˆ๋งŒ overload ๊ฑธ๋ ค๋„ ๋ถ€์ข… ๋ฐœ์ƒ
: ํ, ๋‡Œ ๋ฌธ์ œ๊ฐ€ ์žˆ์œผ๋ฉด ํ˜ˆ๊ด€ ํˆฌ๊ณผ์„ฑ๋„ ์ฆ๊ฐ€ โ†’ fluid ๋งŽ์ด ๋น ์ ธ๋‚˜๊ฐ
: Aggressiveํ•˜๊ฒŒ ์“ฐ๋ฉด ์ ˆ๋Œ€ ์•ˆ ๋จ! LFVR ์ ์šฉ.

1๏ธโƒฃ Types of Crystalloid

ํ˜ˆ์žฅ์˜ osmolality = 290-310mOsm/L (dog) ์ •๋„.

Isotonic (๋“ฑ์žฅ์„ฑ)Hypotonic (์ €์žฅ์„ฑ)Hypertonic (๊ณ ์žฅ์„ฑ)
ํ˜ˆ๊ด€๋‚ด 30๋ถ„ ๋จธ๋ฌผ๊ณ  ๊ฐ„์งˆ๋กœ ํผ์ง
: Resuscitation + Maintenance ๋ชฉ์ 
ํ˜ˆ๊ด€์— ๊ฑฐ์˜ ๋จธ๋ฌผ์ง€ ์•Š๊ณ 
๋‹ค ์„ธํฌ ์ˆ˜์ค€์œผ๋กœ ๋น ์ง
: ์™„์ „ Maintenance ๋ชฉ์ 
ํ˜ˆ๊ด€ ๋‚ด ์‚ผํˆฌ์••์„ ์ผ์‹œ์ ์œผ๋กœ ์ฆ๊ฐ€์‹œ์ผœ
์ฃผ๋ณ€ fluid๋ฅผ ๋Œ์–ด์˜ด
: Resuscitation ํšจ๊ณผ์ 
ํ˜ˆ์žฅ ์‚ผํˆฌ์™€ ๋น„์Šท (290 ์ „ํ›„)ํ˜ˆ์žฅ ์‚ผํˆฌ์˜ ์ ˆ๋ฐ˜ ์ •๋„ (150)์—„์ฒญ๋‚˜๊ฒŒ ๋†’์Œ (2500)
Isotonic

๋“ฑ์žฅ์„ฑ ์ˆ˜์•ก์€ ํ˜ˆ๊ด€๋‚ด์— 30๋ถ„ ๋จธ๋ฌผ๊ณ  ๊ฐ„์งˆ๋กœ ํผ์ง. โ‡’ Resuscitation + Maintenance ๋ชฉ์ ์œผ๋กœ ์‚ฌ์šฉ๋จ.
* ํ˜ˆ์žฅ์˜ pH๋Š” 7.3-7.4 ์ •๋„์˜ ์ค‘์„ฑ, CPA ๋ฐœ์ƒ ์‹œ pH 6.7 ์ •๋„.
* Balanced solution = Plasma-Lyte, Hartman, Normosol ๋“ฑ์€ ํ˜ˆ์žฅ pH์™€ ๋น„์Šทํ•˜๊ฒŒ ์ค‘์„ฑ์ธ ์ˆ˜์•ก. : ์ค‘ํ™˜์ž ์˜ํ•™์—์„œ ์„ ํ˜ธ๋จ. ์ค‘ํƒ„์‚ฐ์„ ๋งŒ๋“ค์–ด๋‚ด์„œ ์ถ”๊ฐ€์ ์œผ๋กœ ์•Œ์นผ๋ฆฌํ™” ํšจ๊ณผ.
* Normal saline์€ ์‚ฌ์‹ค pH 5.0์œผ๋กœ ๊ฐ•์‚ฐ์„ฑ์ด๊ณ , ์ฒด๋‚ด๋ฅผ ์‚ฐ์„ฑํ™”์‹œํ‚ด. (์‚ฐ์ฆ ํ™˜์ž์—์„œ ์œ„ํ—˜)

  • Lactated Ringerโ€™s solution (= Hartman) : ์ค‘์„ฑ์— ๊ฐ€๊นŒ์›€ (pH6.5)
  • Normosol : ์ค‘์„ฑ์— ๊ฐ€๊นŒ์›€ (pH6.4)
  • Plasma-Lyte A : ๊ฐ€์žฅ ์ค‘์„ฑ์— ๊ฐ€๊นŒ์›€, ์ค‘ํ™˜์ž์—์„œ ๊ฐ€์žฅ ๋งŽ์ด ์”€.
  • Normal Saline (0.9% NaCl) : Chloride๊ฐ€ ๋งŽ์•„ ๊ฐ•์‚ฐ์„ฑ (pH5.0) (์‚ฌ์‹ค normal ์•„๋‹˜ )
    • ํ˜ˆ์žฅ ์ „ํ•ด์งˆ ๊ตฌ์„ฑ๊ณผ ๋‹ค๋ฆ„ & ์‚ฐ์ฆ์ธ ํ™˜์ž์—์„œ ์“ฐ๋ฉด ์•ˆ ๋จ & AKI ์œ ๋ฐœ ๊ฐ€๋Šฅ
    • [indication] ๊ฐ•์‚ฐ์„ฑ์ด๋‹ˆ๊นŒ โ‡’ metabolic alkalosis, hypochloremia ์ผ ๋•Œ / potassium, calcium ์—†์œผ๋‹ˆ๊นŒ โ‡’ hypercalcemia, w. citrate blood products ์ผ ๋•Œ
Hypotonic

์ €์žฅ์„ฑ ์ˆ˜์•ก์€ ํ˜ˆ๊ด€ ๋‚ด์— ๊ฑฐ์˜ ๋จธ๋ฌผ์ง€ ์•Š๊ณ , ์„ธํฌ ์ˆ˜์ค€์œผ๋กœ ์ซ™ ๋น ์ง. โ‡’ ์™„์ „ Maintenance ๋ชฉ์ 

  • 0.45% NaCl : sodium ์ˆ˜์น˜ ๋‚ฎ์Œ = fluid overload ๋œํ•จ
    • [use] Hypernatremia ์น˜๋ฃŒ / CHF, renal disease ํ™˜์ž (sodium load์˜ ๋ถ€๋‹ด ์žˆ๋Š” ํ™˜์ž)
    • [avoid] Hyponatremia ํ™˜์ž / SIADH, positive-pressure ventilation, RAAS ํ•ญ์ง„ ์‹œ (sodium ์ด๋ฏธ ๋‚ฎ์€ ํ™˜์ž)
  • D5W
Hypertonic

๊ณ ์žฅ์„ฑ ์ˆ˜์•ก์€ ํ˜ˆ๊ด€ ์•ˆ์— ๋จธ๋ฌด๋ฅด์ง€๋Š” ์•Š์ง€๋งŒ, ํ˜ˆ๊ด€๋‚ด ์‚ผํˆฌ์••์„ ์ผ์‹œ์ ์œผ๋กœ ์ฆ๊ฐ€์‹œ์ผœ ์ฃผ๋ณ€ fluid๋ฅผ ๋Œ์–ด์˜ด. โ‡’ Resuscitation์— ํšจ๊ณผ์ .
* Colloid์™€ ํšจ๊ณผ๋Š” ๋น„์Šทํ•˜์ง€๋งŒ, ์ „ํ•ด์งˆ base์ธ ๋งŒํผ ์ง€์† ์‹œ๊ฐ„์ด 30๋ถ„ ์ •๋„๋กœ ์งง์Œ.
โ‡’ ๋ณ‘์šฉํ•˜์—ฌ ์“ฐ๊ธฐ๋„ ํ•จ. (hypertonic + colloid = Turbo starch)
* LFVR๋กœ ์จ์•ผ ํ•จ (์šฉ๋Ÿ‰์ด ๋งŽ์ด ๋ปฅํŠ€๊ธฐ๋˜๋‹ˆ๊นŒ)

  • 7.5% NaCl ๋“ฑ

โ€ป Potassium ๋ถ€์กฑํ•  ์‹œ KCl ์•ฐํ”Œ์„ ์ˆ˜์•ก์— ํƒ€์„œ ์ถ”๊ฐ€ ๊ณต๊ธ‰ํ•œ๋‹ค. Hyperkalemia๋ฅผ ์œ ๋ฐœํ•˜์ง€ ์•Š๋„๋ก maximum ์†๋„๋ณด๋‹ค ์•„๋ž˜๋กœ ์ฃผ์ž….

2๏ธโƒฃ Types of Colloid

  • Colloid๋Š” ๊ต์งˆ ๋†๋„๋ฅผ ๋†’์—ฌ ํ˜ˆ๊ด€ ๋ฐ–์˜ fluid๋ฅผ ์•ˆ์ชฝ์œผ๋กœ ์ซ™ ๋Œ์–ด๋‹น๊ธด๋‹ค.
  • ์‚ผํˆฌ์••์˜ ์œ ์ง€์—๋Š” albumin์ด 80% + RBC ๋˜ํ•œ ์ค‘์š”ํ•œ ์—ญํ• ์„ ํ•œ๋‹ค.
Natural

= blood product. ๋งŽ์€ ์–‘์ด ํ•„์š”ํ•จ์—๋„ ๋ถˆ๊ตฌํ•˜๊ณ , ํ•ฉ์„ฑ ์ œ์ œ๋ณด๋‹ค ์•ˆ์ •์„ฑ์ด ๋†’์•„ ์ตœ๊ทผ ๊ถŒ์žฅ๋˜๋Š” ์ถ”์„ธ.

  • Whole blood (์ „ํ˜ˆ)
  • Plasma
  • Albumin :
    • CSA(Canine serum albumin)๋ณด๋‹ค HSA(Human ~)๊ฐ€ ๊ตฌํ•˜๊ธฐ ์‰ฝ๊ณ , ์ถฉ๋ถ„ํžˆ ํšจ๊ณผ์ .
    • hypersensitivity ์ฃผ์˜ (์šฉ๋Ÿ‰ 2g/kg/day๋กœ ์ œํ•œ)
Synthetic
  • Dextran
  • Gelatin
  • HES (Hydroxyethyl starch) : ์ „๋ถ„์„ ์ •์ œ, ์›๋ž˜ ๋งŽ์ด ์ผ์œผ๋‚˜ ๋‹จ์ ์ด ๋ถ€๊ฐ๋˜๊ณ  ์žˆ์Œ. (6%, 130๋‹ฌํ†ค)
    • ์‚ผํˆฌ๋ฅผ ์œ ์ง€ํ•ด์„œ volume resuscitation ๊ฐ€๋Šฅ โ†’ ๊ทธ ์™ธ ์•Œ๋ถ€๋ฏผ ๊ธฐ๋Šฅ์€ ๋Œ€์ฒด ๋ถˆ๊ฐ€.
    • ์ถฉ๋ถ„ํžˆ ์ˆ˜ํ™”(rehydration)์‹œํ‚จ ๋’ค ์‚ฌ์šฉ !!
    • 20ml/kg/day ์ดˆ๊ณผ X โ†’ ๋ถ€์ž‘์šฉ AKI, coagulopathy, volume overload, allergic reaction

โœณ๏ธ Fluid responsiveness

  • Fluid responsive : cardiac output, stroke volume ์ถฉ๋ถ„ํžˆ ์ฆ๊ฐ€ํ•จ
  • Fluid Non-responders : ๋‘˜ ๋‹ค ์ฆ๊ฐ€ํ•˜์ง€ ์•Š๊ณ  ์˜คํžˆ๋ ค lactate๋งŒ ๊ณ„์† ์˜ค๋ฆ„. โ‡’ ๋ณด๋‹ค ๊ทผ์›์ ์ธ ์›์ธ ๊ต์ • ํ•„์š”!
    • SIRS, sepsis, ๊ธ‰์„ฑ ์ „์‹ ์—ผ์ฆ โ‡’ ์Šน์••์ œ ๊ณ ๋ ค
    • Hypoalbuminemia โ‡’ ํ˜ˆ์••์ด ์˜ฌ๋ž๋‹ค๊ฐ€๋„ ๊ณ„์† ๋–จ์–ด์ง. ์•Œ๋ถ€๋ฏผ ์ˆ˜ํ˜ˆ ๊ณ ๋ ค

ํ™•์ธ ๋ฐฉ๋ฒ•

์ž„์ƒ์ ์œผ๋กœ ํ˜ˆ์•• ์ธก์ • ์ด ์ œ์ผ. (๋ฐ˜์‘์„ฑ ์ข‹์œผ๋ฉด ํ˜ˆ์••์ด ์ƒ์Šน)

Non-responsive ์ง€ํ‘œ
  • low BP ์ง€์†
  • lactate ์ฆ๊ฐ€
  • persistent LV filling, No collapse in vena cava (์ •์ˆ˜์•• ์ถฉ๋ถ„)
  • VTI < 10-15%, PPV < 11-16%

โ‡’ ์Šน์••์ œ ์‚ฌ์šฉ ๊ณ ๋ ค(distributive shock), ๊ต์งˆ ์‚ผํˆฌ์•• ๊ต์ •

3. IV Fluid therapy์˜ Four stage : ROSE

Rescue (Resuscitate)OptimizationStabilizationEvacuation
๋งŽ์€ ์–‘์„ ๊ณต๊ฒฉ์ ์œผ๋กœ
- Bolus ํˆฌ์—ฌ (10ml/kg ์ •๋„, <30ml/kg)
๋ฐ˜์‘์„ฑ์„ ํ™•์ธํ•˜๋ฉด์„œ ์ตœ์ ํ™”
(์šฉ๋Ÿ‰ ๋งž์ถฐ๊ฐ€๊ณ ,
vasopressor ์“ธ์ง€ ๋ง์ง€)
์•ˆ์ •ํ™” ์œ ์ง€
rehydration,
ongoing loss ์ฑ„์›Œ์คŒ
์ ์ฐจ ์ค„์—ฌ์คŒ

4. Maintenance & Monitoring

โœณ๏ธ ์œ ์ง€์šฉ๋Ÿ‰ ๊ณต์‹

Maintenance + Dehydration + Ongoing loss

  • (1) Maintenance : ์ž์—ฐ์ ์œผ๋กœ ๋‚ด ๋ชธ์—์„œ ๋น ์ง€๋Š” ์ˆ˜๋ถ„๋Ÿ‰ โ‡’ ๋ณดํ†ต 2.5mL/kg/h (60ml/kg/day)
    • sensible loss : ๊ณ„์‚ฐ ๊ฐ€๋Šฅ, ๋ฐฐ๋‡จ๋Ÿ‰, ๊ฑด๊ฐ•ํ•œ ๊ฐœ์ฒด์—์„œ๋Š” 1.5ml/kg ์ •๋„.
    • insensible loss : ํ˜ธํก์ด๋‚˜ ๋•€ ๋“ฑ ๊ณ„์‚ฐ ๋ถˆ๊ฐ€, ๋Œ€๋žต 1ml/kg ์ •๋„๋กœ ์žก์Œ
    • ์ฆ‰, urine output + 1 ๋กœ ๊ณ„์‚ฐ
  • (2) Dehydration : BW (kg) ร— % dehydration ร— 1000 (ml/day)
  • (3) Ongoing loss : ๊ตฌํ† , ์„ค์‚ฌ, ์ถœํ˜ˆ ๋“ฑ (์ •ํ™•ํ•œ ์ถœํ˜ˆ์€ ์–ด๋ ค์›€)

(1) + (2) + (3) ์˜ ์šฉ๋Ÿ‰์„ 6-24์‹œ๊ฐ„ ๋™์•ˆ ๊ต์ •ํ•˜๋˜, Maintenace์˜ 2๋ฐฐ๋ฅผ ๋„˜์ง€ ์•Š๋Š”๋‹ค.

โœณ๏ธ Fluid creep (๋ณ€์ˆ˜)

์ˆ˜์•ก ์ฒ˜์น˜๋ฟ๋งŒ ์•„๋‹ˆ๋ผ delivery๋ฅผ ์œ„ํ•ด ํ•จ๊ป˜ ๋“ค์–ด๊ฐ€๋Š” ์šฉ๋Ÿ‰์ด ๋ฌด์‹œ ๋ชปํ•  ๋งŒํผ ํฌ๋‹ค๋Š” ๊ฒƒ. (์ฃผ์‚ฌ์ œ, ํ˜ˆ์•ก ์ œ์ œ, ๋ฌด์–ธ๊ฐ€๋ฅผ ํฌ์„ํ•ด์„œ ๋„ฃ์–ด์ฃผ๋Š” ๊ฒƒ ๋“ฑ)

  • ์ด๋Ÿฐ creep์„ ์•Œ๊ณ  ์žˆ์„ ๊ฒƒ.
  • ์•ฝ๋ฌผ์„ ์ ๊ฒŒ ํฌ์„ํ•˜๊ณ , ๊ฐ€๋Šฅํ•œ DW์— ํฌ์„ํ•  ๊ฒƒ.

โœณ๏ธ Fluid overload ํ‰๊ฐ€ & ์กฐ์น˜ & ์˜ˆ๋ฐฉ

Preventing Fluid Overload! : ๊ณผํ•œ fluid๋กœ ๋ฌธ์ œ๋  ๋•Œ๊ฐ€ 90% ์ด์ƒ. ์˜ˆ๋ฐฉ์„ ์ž˜ํ•˜์ž!

  • BW & Urine ouput์„ ์ง€์†์ ์œผ๋กœ ๋ชจ๋‹ˆํ„ฐ๋ง & ์žฌํ‰๊ฐ€ํ•ด์„œ fluid๊ฐ€ ๊ณผํ•˜๊ฒŒ ๋“ค์–ด๊ฐ€์ง€ ์•Š๋Š”์ง€ ํ™•์ธํ•ด์•ผ ํ•จ.
    • ์ฒด์™ธ๋กœ ๋ฐฐ์ถœ๋˜์ง€ ๋ชปํ•œ fluid๋Š” ๊ฐ„์งˆ์— ์Œ“์—ฌ ๋ถ€์ข…์„ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ๊ธฐ ๋•Œ๋ฌธ.
    • ๊ฐ„์งˆ์— ์Œ“์ด๋ฉด ์ฒด์ค‘์ด ๊ฐ€์žฅ ๋จผ์ € ์ฆ๊ฐ€ํ•จ.
Indicator
  • BW ์ฆ๊ฐ€ (> 5~10%) : ๊ฐ€์žฅ ์ค‘์š”ํ•œ indicator
    • ์ฒด์ค‘์ด 5-10% ์ด์ƒ ์ฆ๊ฐ€ํ•˜๋ฉด ๋ฐ”๋กœ.. โ‡’ 1) ์†Œ๋ณ€ ์œ ๋„ (๋ฐฉ๊ด‘ ๋น„์šฐ๊ธฐ), 2) ์ˆ˜์•ก ์šฉ๋Ÿ‰ ํ™•์ธ
  • Hypertension : ์ •์ˆ˜์•• ์ƒ์Šน โ†’ ๊ฐ€์žฅ ๋จผ์ € ํ˜ˆ์•• ์ฆ๊ฐ€
  • resting respiratory rate ์ฆ๊ฐ€
  • Pulmonary edema : ๊ฐ€์žฅ ๋จผ์ € ๋‚˜ํƒ€๋‚˜๋Š” ํŽธ
  • Pitting edema : ๋ˆŒ๋ €์„ ๋•Œ ์ž๊ตญ์ด ์˜ค๋ž˜๊ฐ
  • Chemosis(๊ฒฐ๋ง‰ ๋ถ€์ข…), nasal dischage, HR ์ฆ๊ฐ€, shivering

1% overload ๋  ๋•Œ ์‚ฌ๋ง๋ฅ ์€ 8% ์ฆ๊ฐ€ํ•จ!

  • ๊ทธ ์™ธ ์ดˆ์ŒํŒŒ์—์„œ์˜ sign
    • B lines (ํ์‹ค์งˆ์— ์•ก์ฒด๊ฐ€ ์Œ“์—ฌ ๋‚˜ํƒ€๋‚˜๋Š” hyperechoic line; 3-4๊ฐœ ์ด์ƒ)
    • LA:Ao ratio ์ฆ๊ฐ€
    • Pleural effusion, Pericardial effusion
    • Non-collapsible vena cava
Therapy
  • ์ˆ˜์•ก ๋ฐ”๋กœ ์ค‘๋‹จ!
  • Diuretics (furosemide) : ๊ฐ„์งˆ ๋ถ€์ข…, ํ๋ถ€์ข…์—์„œ ์—„์ฒญ๋‚œ ํšจ๊ณผ (0.2-0.5mg/kg, up to 1mg/kg)
    • ๋‹จ, ์ถฉ๋ถ„ํžˆ ์ˆ˜ํ™”๋˜์ง€ ์•Š์€ ์ƒํƒœ์—์„œ ์“ฐ๋ฉด ์‹ ์žฅ ๊ด€๋ฅ˜๋Ÿ‰์ด ๊ฐ์†Œํ•ด AKI ๊ฐ€๋Šฅ์„ฑ โ†‘
  • Increase mobility : ๊ณ„์† ์›€์ง์ด๊ฒŒ ํ•ด์„œ ๊ด€๋ฅ˜๋ฅผ ์ฆ๊ฐ€์‹œํ‚ด
  • ํ‰์ˆ˜, ๋ณต์ˆ˜ ์ œ๊ฑฐ
Prevention

์• ์ดˆ์— ์ž˜ ์˜ˆ๋ฐฉํ•˜๋Š” ๊ฒŒ ํ›จ์”ฌ ์ข‹๋‹ค!!

  • low-volume strategy (LFVR)
  • Fluid creep์„ ์ •ํ™•ํ•˜๊ฒŒ ๊ณ„์‚ฐํ•˜์ง„ ๋ชปํ•˜๋”๋ผ๋„, ํ•ญ์ƒ ์ธ์ง€ํ•˜๊ณ  ์ฃผ์˜ํ•˜๊ธฐ!
  • ์ฒด์ค‘ ๋ชจ๋‹ˆํ„ฐ๋ง์„ ๊พธ์ค€ํžˆ, ์ž์ฃผ (q6-12h)